Treatment search

The first infographic guiding the treatment journey for female urinary incontinence is published in the Journal of Women’s Health

Visual tool provides easy access to factual literature and company recommendations for a comprehensive approach to screening and treatment of UI in women

BOSTON, March 23, 2022 Renovia Inc. (“Renovia”), a women-led company developing digital prescription therapies for female pelvic floor disorders, applauds the authors of a visual tool and accompanying story published in the Journal of Women’s Health which synthesizes the compendium of literature and professional Guidelines for screening, evaluation and treatment of female urinary incontinence. The infographic’s compelling visual format serves as a first-of-its-kind shared decision-making tool to facilitate a population-based approach to UI education and treatment at scale.

While moderate to more severe UI affects more than 28 million women in the United States, effective first-line treatment remains largely inaccessible with less than 25% seeking care. The open-access manuscript and infographic, “Female Urinary Incontinence Evidence-Based Treatment Pathway: An Infographic for Shared Decision-Making,” aims to increase access to treatment, including first-line therapy, such as training of the pelvic floor muscles (PFMT), presenting evidence-based guidelines for the screening and treatment of UI in an easy-to-access graphic format for use by clinicians on the front lines of patient health. women. Professional organizations and healthcare systems may also find it useful for training clinicians and members.

Infographic outlines female risk factors for UI, influences on care-seeking, screening and assessment. It also includes a stepwise treatment approach, for which there is broad international and multidisciplinary agreement. It synthesizes current evidence-based literature as well as multiple UI screening guidelines, position statements, and related references from the American College of Obstetricians and Gynecologists, the Women’s Preventive Services Initiative, the American Academy of Family Physicians, American College of Physicians, Society of Urodynamics and Female Urology, American Urological Association, and American Urogynecologic Society.

Study authors include Renovia’s Chief Medical Officer Samantha J. PulliamMD, Vice President of Medical Affairs and Clinical Advocacy, Jessica L. McKinneyPT, DScPT, MS, and Senior Director of Medical Affairs, Laura E. Keyser, TPD, MPH. Commenting on the study, Dr Pulliam said: “Female urinary incontinence is arguably a public health crisis in the United States, with more than 50% of women age 50 and older affected. It is also a progressive health problem that is unlikely to resolve itself without treatment or symptoms. It’s burdensome – socially, economically and psychologically – and can contribute to other significant and potentially serious medical conditions. While there is universal consensus for primary care, which includes PFMT, there are multiple issues emotional, socio-cultural, structural, and economic barriers combined with women’s difficulty performing strength exercises correctly on their own, which keeps primary care out of reach Infographic provides a simple and engaging way to diagnose and treat female UI according to evidence-based guidelines improve the number of women who can access first-line treatment No woman should have to live with a co-condition.”

Additionally, Dr. McKinney said, “The reality is that UI goes untreated for most women, from those in need of first-line care to advanced therapies. Our team has worked to create a resource for healthcare professionals and patients to facilitate conversations and decisions about treatment. . We are delighted to share our work in the Journal of Women’s Health and further delighted that the timing of print publication coincided with March’s significant societal focus on women’s history. Among the many women who have contributed to the field of pelvic health are Minnie Randal and margaret morris, a British midwife and physiotherapist respectively, who wrote and taught in the UK and US in the 1930s on the importance of exercising the pelvic floor muscles. Almost a century later, we recognize that we still rely on their work.”

About Renovia
BostonRenovia Inc. is a women-led company dedicated to improving the lives of women with pelvic floor disorders. Renovia’s flagship product, the raised® Pelvic health system, offers a new, effective front-line treatment for urinary incontinence (UI), an underreported condition experienced by more than 78 million women in the United States alone. Renovia’s technology enables non-invasive, drug-free treatment through accurate visualization of real-time movement during pelvic floor muscle training, while monitoring usage and progress. For more information on Renovia or raised please visit www.renoviainc.com and www.levatherapy.com and follow us on TwitterFacebook, LinkedIn and Instagram.

Important instructions and other information for the raised Pelvic health system
the raised Pelvic Health System is intended for strengthening pelvic floor muscles and rehabilitating and training weak pelvic floor muscles for the treatment of mild to moderate stress, mixed and urge urinary incontinence (including overactive bladder) in women. Treatment with the raised The system is prescription and is not for everyone. Please speak to your prescribing physician to see if raised is good for you. Your prescriber should discuss all potential benefits and risks with you. Do not use raised during pregnancy or if you think you may be pregnant, unless approved by your doctor. For a full summary of the risks and instructions for raised system, consult its instructions for use available on www.renoviainc.com and www.levatherapy.com.

Renovia Inc. and raised® are trademarks or registered trademarks of Renovia Inc. in United States and other countries. All rights reserved.

Media inquiries:
Shanti Skiffington
mobile: 617 921-0808

SOURCE Renovia Inc.